DUO:0000006
version: 2021-02-23

health or medical or biomedical research

This data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.

DUO:0000024
version: 2021-02-23

publication moratorium

This data use modifier indicates that requestor agrees not to publish results of studies until a specific date.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

DAA_required_UMGC

To protect patient privacy, access to the data is subject to the signing of a specific Data Access Agreement. Please contact the lead investigator by email to request the form.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID	Study Title	Study Type
EGAS50000001236	Non-neuronal TGF-β–mediated extracellular matrix remodeling drives neurodegeneration in a PSP-Richardson syndrome model	Whole Genome Sequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID	File Type	Size
EGAF50000425214	bam	60.7 GB
EGAF50000425215	bam	44.5 GB
EGAF50000425216	bam	43.4 GB
EGAF50000425217	bam	53.9 GB
EGAF50000425218	bam	53.9 GB
EGAF50000425219	bam	45.3 GB
EGAF50000425220	bam	37.5 GB
7 Files (339.2 GB)

BAM file s of WGS data of Progressive supranuclear palsy patients

DUO:0000006 version: 2021-02-23